Explore evidence

1,723 individualsAmong 11,070 people with HIV (PWH) with AUDIT-C measured, 1723 (16%) reported any alcohol use.

KenyaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

28 %Of 25 participants with incident HIV infection, 7/25 (28%) reported taking PrEP ≤30 days before HIV diagnosis.

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations

Among persons with HIV on long-term antiretroviral therapy, higher BMI >30 kg/m2 was associated with hypertension.

Kenyahypertension artérielle · VIH/sidaobserved September 2017 to May 2018published 2022PloS onePubMeddocument of 6 observations

55 %Most of the anaemia was dimorphic in HIV-negative non-injection substance users (55%).

Kenyaanémie · VIH/sidapublished 2022African health sciencesPubMeddocument of 7 observations

1.93 aPRPast physical violence was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 1.93.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

57.6 %Among 720 participants living with HIV in southwestern Kenya, 57.6% of women reported experiencing intimate partner violence.

KenyaVIH/sidaobserved January 2016-December 2017published 2021American journal of preventive medicinePubMeddocument of 6 observations

34 seroconversionsThirty-four seroconversions occurred within 30 days of PrEP initiation.

KenyaVIH/sidaobserved December 2017 through September 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 13 observations

0.4 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 0.4% had hairy leukoplakia as the only oral lesion.

Kenyahairy leukoplakia · VIH/sidapublished 1989Journal of Oral Pathology and MedicineOpenAlexdocument of 8 observations

1.52 fold_increaseTrichomoniasis was associated with a 1.52-fold increased risk of HIV-1 acquisition after adjustment for potential confounding factors among HIV-1-seronegative women in Mombasa, Kenya.

Kenyatrichomoniasis · VIH/sidapublished 2007The Journal of infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1086/511278

1.1 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 1.1% had hyperplastic candidiasis as the only oral lesion.

Kenyahyperplastic candidiasis · VIH/sidapublished 1989Journal of Oral Pathology and MedicineOpenAlexdocument of 8 observations

97 %Among ART-experienced persons with baseline viral suppression, viral suppression at year 3 was 97% in the intervention arm and 95% in the control arm.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations

4.7 %Few pregnant women living with HIV in Kenya reported delaying antenatal care because of COVID-19 (4.7%).

KenyaCOVID-19 · VIH/sidaobserved October 2020 to July 2022published 2024BMC pregnancy and childbirthPubMeddocument of 4 observations

592,000 individualsIn 2018, the model projected 592,000 individuals in need of antiretroviral therapy (ART) in Kenya.

KenyaVIH/sidaobserved 2018published 2020Journal of the International AIDS SocietyPubMeddocument of 10 observations

4.54 relative_riskMaternal non-disclosure of HIV status to partner(s) was associated with a relative risk of 4.54 for infant HIV positivity at 12 months.

KenyaVIH/sidaobserved 12 monthspublished 2023European Journal of Public HealthOpenAlexdocument of 7 observationsDOI 10.1093/eurpub/ckad160.824

80 %The mean proportion of participants with virological suppression at 2 years was 80% for participants in control clinics.

KenyaVIH/sidapublished 2023The lancet. HIVPubMeddocument of 8 observations

62 %Overall, 62% of vaccine recipients in the rAd5 alone group responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT.

KenyaVIH/sidapublished 2010PloS oneeurope_pmcdocument of 4 observations

-0.04 percentage_pointsThe difference in percentage of participants meeting the primary end point between the dolutegravir and ritonavir-boosted PI groups was -0.04 percentage points at week 48.

KenyaVIH/sidaobserved week 48published 2023The New England journal of medicinePubMeddocument of 8 observations

11 %Among children living with HIV who were active on treatment, those who aged out of childhood ranged between 11% and 13%.

KenyaVIH/sidapublished 2025The Pediatric infectious disease journalPubMeddocument of 10 observations

2.76 aORUsing opioid agonist therapy was associated with increased ART coverage among people living with HIV (adjusted odds ratio = 2.76; 95% CI: 1.50–5.06).

KenyaVIH/sidapublished 2025The International journal on drug policyPubMeddocument of 10 observations

18 individualsAmong 348 women in a 2-year study of young women at high HIV risk in Thika and Kisumu, Kenya, 18 (5%) followed a steady high PrEP adherence trajectory.

KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 5 observations

4.5 %HIV prevalence was 4.5% among adolescent girls and young women aged 15–24 years in western Kenya in 2018.

KenyaVIH/sidaobserved 2018published 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations

81.9 %At 3 years, child HIV-free survival was 81.9% overall, 92.0% for children of women retained in care (RW), and 58.6% for children of women lost to follow-up (LW).

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

1.8 relative_riskCompared with the $0 arm, caregivers in the $10.00 arm had significantly higher uptake of child HIV testing, with a relative risk of 1.80 (95% CI 1.15–2.80), P = 0.010.

KenyaVIH/sidapublished 2021AIDS (London, England)PubMeddocument of 3 observations

64 %Sixty-four percent of HIV-1-negative volunteers were positive for Plasmodium 18S, corresponding to 998 out of 1,569 individuals.

Kenyapaludisme · VIH/sidapublished 2021The American journal of tropical medicine and hygienePubMeddocument of 7 observations

2 casesTwo HIV seroconversions occurred during follow-up: one at 12 months and one at 18 months of follow-up.

KenyaVIH/sidapublished 2026AIDS and behaviorPubMeddocument of 10 observations